Study characters
| Study characters (N=62) | |
| Region | |
| Africa | 53 |
| Asia & Pacific | 7 |
| Europe | 1 |
| America | 1 |
| Year of study publication | 1998–2021 |
| Study method | |
| In-depth Interview | 33 |
| Focus group discussion | 7 |
| Mixed method | 18 |
| Service delivery level 1 | |
| Community | 8 |
| Clinic | 32 |
| Hospital | 32 |
| Number of target diseases | |
| HIV | 54 |
| Syphilis | 4 |
| Both | 4 |
| Target participants* | |
| Pregnant women | 51 |
| Health providers | 40 |
| Stakeholders | 23 |
Stakeholder: including were defined as anyone who may influence rapid testing uptake, such as, health facility managers, local or international collaborator and policy makers.
*Aggregate data are presented.